265 related articles for article (PubMed ID: 26194764)
1. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
Donadieu J; Bernard F; van Noesel M; Barkaoui M; Bardet O; Mura R; Arico M; Piguet C; Gandemer V; Armari Alla C; Clausen N; Jeziorski E; Lambilliote A; Weitzman S; Henter JI; Van Den Bos C;
Blood; 2015 Sep; 126(12):1415-23. PubMed ID: 26194764
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent and Refractory Langerhans Cell Histiocytosis in Children Treated with the Combination of Cladribine and Cytarabine].
DU Y; Xiong H; Li H; Li JX; Tao F; Yang L; Lu WJ; Qi SS; Zhang LN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):943-949. PubMed ID: 35680831
[TBL] [Abstract][Full Text] [Related]
3. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis].
Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X
Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of intermediate-dose cytarabine in the treatment of children with refractory high risk Langerhans cell histiocytosis].
Wang WQ; Ge J; Ma HH; Lian HY; Cui L; Zhang L; Li ZG; Wang TY; Zhang R
Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1118-1123. PubMed ID: 38018049
[No Abstract] [Full Text] [Related]
5. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine.
Choi SW; Bangaru BS; Wu CD; Finlay JL
J Pediatr Hematol Oncol; 2003 Jun; 25(6):503-6. PubMed ID: 12794533
[TBL] [Abstract][Full Text] [Related]
6. Risk organ + LCH gets the one-two punch?
Stine KC
Blood; 2015 Sep; 126(12):1399-400. PubMed ID: 26384280
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cell histiocytosis, a case of Letterer Siwe disease.
Pant C; Madonia P; Bahna SL; Bass PF; Jeroudi M
J La State Med Soc; 2009; 161(4):211-2. PubMed ID: 19785312
[TBL] [Abstract][Full Text] [Related]
8. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review.
Néel A; Artifoni M; Fontenoy AM; Tessoulin B; Lorillon G; Cohen-Aubart F; Haroche J; Genereau T; de Menthon M; Guillevin L; Maillard H; Kahn JE; Hermine O; Araujo C; Dromer C; Jullien D; Hamidou M; Donadieu J; Tazi A
Br J Haematol; 2020 Jun; 189(5):869-878. PubMed ID: 32191819
[TBL] [Abstract][Full Text] [Related]
10. Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH.
Evseev D; Osipova D; Kalinina I; Raykina E; Ignatova A; Lyudovskikh E; Baidildina D; Popov A; Zhogov V; Semchenkova A; Litvin E; Kotskaya N; Cherniak E; Voronin K; Burtsev E; Bronin G; Vlasova I; Purbueva B; Fink O; Pristanskova E; Dzhukaeva I; Erega E; Novichkova G; Maschan A; Maschan M
Blood Adv; 2023 Sep; 7(18):5246-5257. PubMed ID: 37216396
[TBL] [Abstract][Full Text] [Related]
11. Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study.
Donadieu J; Larabi IA; Tardieu M; Visser J; Hutter C; Sieni E; Kabbara N; Barkaoui M; Miron J; Chalard F; Milne P; Haroche J; Cohen F; Hélias-Rodzewicz Z; Simon N; Jehanne M; Kolenova A; Pagnier A; Aladjidi N; Schneider P; Plat G; Lutun A; Sonntagbauer A; Lehrnbecher T; Ferster A; Efremova V; Ahlmann M; Blanc L; Nicholson J; Lambilliote A; Boudiaf H; Lissat A; Svojgr K; Bernard F; Elitzur S; Golan M; Evseev D; Maschan M; Idbaih A; Slater O; Minkov M; Taly V; Collin M; Alvarez JC; Emile JF; Héritier S
J Clin Oncol; 2019 Nov; 37(31):2857-2865. PubMed ID: 31513482
[TBL] [Abstract][Full Text] [Related]
12. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review].
Yao X; Ying H; Weihong Z; Qing S; Xintian L
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
[TBL] [Abstract][Full Text] [Related]
14. Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone.
Wang W; Ge J; Ma H; Lian H; Cui L; Zhao Y; Li Z; Wang T; Zhang R
BMC Pediatr; 2024 Jan; 24(1):1. PubMed ID: 38172736
[TBL] [Abstract][Full Text] [Related]
15. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
Apollonsky N; Lipton JM
J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
[TBL] [Abstract][Full Text] [Related]
16. Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis.
Rosso DA; Amaral D; Latella A; Chantada G; Braier JL
Br J Haematol; 2016 Jan; 172(2):287-90. PubMed ID: 25944303
[No Abstract] [Full Text] [Related]
17. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.
Bernard F; Thomas C; Bertrand Y; Munzer M; Landman Parker J; Ouache M; Colin VM; Perel Y; Chastagner P; Vermylen C; Donadieu J
Eur J Cancer; 2005 Nov; 41(17):2682-9. PubMed ID: 16291085
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine.
Mottl H; Starý J; Chánová M; Nekolná M; Drahokoupilová E; Smelhaus V
Leuk Lymphoma; 2006 Sep; 47(9):1881-4. PubMed ID: 17065001
[TBL] [Abstract][Full Text] [Related]
19. [Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients].
Grau J; Ribera JM; Tormo M; Indiano JM; Vercher J; Sandoval V; Ramírez G; Sastre A; Flores E; García-Conde J
Med Clin (Barc); 2001 Mar; 116(9):339-42. PubMed ID: 11333766
[TBL] [Abstract][Full Text] [Related]
20. The global challenge of treating disseminated LCH.
Gulati N
Pediatr Hematol Oncol; 2020 Nov; 37(8):653-655. PubMed ID: 33439096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
